These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10534407)

  • 1. Characterization of copine VII, a new member of the copine family, and its exclusion as a candidate in sporadic breast cancers with loss of heterozygosity at 16q24.3.
    Savino M; d'Apolito M; Centra M; van Beerendonk HM; Cleton-Jansen AM; Whitmore SA; Crawford J; Callen DF; Zelante L; Savoia A
    Genomics; 1999 Oct; 61(2):219-26. PubMed ID: 10534407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation.
    Kittiniyom K; Mastronardi M; Roemer M; Wells WA; Greenberg ER; Titus-Ernstoff L; Newsham IF
    Genes Chromosomes Cancer; 2004 Jul; 40(3):190-203. PubMed ID: 15138999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of the human homologue of SH3BP2, an SH3 binding domain protein within a common region of deletion at 4p16.3 involved in bladder cancer.
    Bell SM; Shaw M; Jou YS; Myers RM; Knowles MA
    Genomics; 1997 Sep; 44(2):163-70. PubMed ID: 9299232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3.
    Kochetkova M; McKenzie OL; Bais AJ; Martin JM; Secker GA; Seshadri R; Powell JA; Hinze SJ; Gardner AE; Spendlove HE; O'Callaghan NJ; Cleton-Jansen AM; Cornelisse C; Whitmore SA; Crawford J; Kremmidiotis G; Sutherland GR; Callen DF
    Cancer Res; 2002 Aug; 62(16):4599-604. PubMed ID: 12183414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic structure of the human tetratricopeptide repeat-containing gene, TTC4, from chromosome region 1p31 and mutation analysis in breast cancers.
    Su G; Casey G; Cowell JK
    Int J Mol Med; 2000 Feb; 5(2):197-200. PubMed ID: 10639601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread.
    Tsuda H; Callen DF; Fukutomi T; Nakamura Y; Hirohashi S
    Cancer Res; 1994 Jan; 54(2):513-7. PubMed ID: 8275489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PISSLRE gene: structure, exon skipping, and exclusion as tumor suppressor in breast cancer.
    Crawford J; Ianzano L; Savino M; Whitmore S; Cleton-Jansen AM; Settasatian C; d'apolito M; Seshadri R; Pronk JC; Auerbach AD; Verlander PC; Mathew CG; Tipping AJ; Doggett NA; Zelante L; Callen DF; Savoia A
    Genomics; 1999 Feb; 56(1):90-7. PubMed ID: 10036189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
    Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
    Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and characterization of LOH11CR2A, a new gene within a refined minimal region of LOH at 11q23.
    Monaco C; Negrini M; Sozzi G; Veronese ML; Vorechovsky I; Godwin AK; Croce CM
    Genomics; 1997 Dec; 46(2):217-22. PubMed ID: 9417908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a high-resolution physical and transcription map of chromosome 16q24.3: a region of frequent loss of heterozygosity in sporadic breast cancer.
    Whitmore SA; Crawford J; Apostolou S; Eyre H; Baker E; Lower KM; Settasatian C; Goldup S; Seshadri R; Gibson RA; Mathew CG; Cleton-Jansen AM; Savoia A; Pronk JC; Auerbach AD; Doggett NA; Sutherland GR; Callen DF
    Genomics; 1998 May; 50(1):1-8. PubMed ID: 9628816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.
    Bednarek AK; Laflin KJ; Daniel RL; Liao Q; Hawkins KA; Aldaz CM
    Cancer Res; 2000 Apr; 60(8):2140-5. PubMed ID: 10786676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining a common region of deletion at 13q21 in human cancers.
    Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT
    Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARHGAP8 is a novel member of the RHOGAP family related to ARHGAP1/CDC42GAP/p50RHOGAP: mutation and expression analyses in colorectal and breast cancers.
    Johnstone CN; Castellví-Bel S; Chang LM; Bessa X; Nakagawa H; Harada H; Sung RK; Piqué JM; Castells A; Rustgi AK
    Gene; 2004 Jul; 336(1):59-71. PubMed ID: 15225876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
    Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
    Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.
    Cleton-Jansen AM; Callen DF; Seshadri R; Goldup S; Mccallum B; Crawford J; Powell JA; Settasatian C; van Beerendonk H; Moerland EW; Smit VT; Harris WH; Millis R; Morgan NV; Barnes D; Mathew CG; Cornelisse CJ
    Cancer Res; 2001 Feb; 61(3):1171-7. PubMed ID: 11221848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SASH1: a candidate tumor suppressor gene on chromosome 6q24.3 is downregulated in breast cancer.
    Zeller C; Hinzmann B; Seitz S; Prokoph H; Burkhard-Goettges E; Fischer J; Jandrig B; Schwarz LE; Rosenthal A; Scherneck S
    Oncogene; 2003 May; 22(19):2972-83. PubMed ID: 12771949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning and characterization of LCRG1 a novel gene localized to the tumor suppressor locus D17S800-D17S930.
    Li Y; Chen Z
    Cancer Lett; 2004 Jun; 209(1):75-85. PubMed ID: 15145523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LAPSER1: a novel candidate tumor suppressor gene from 10q24.3.
    Cabeza-Arvelaiz Y; Thompson TC; Sepulveda JL; Chinault AC
    Oncogene; 2001 Oct; 20(46):6707-17. PubMed ID: 11709705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation analysis of the Fanconi anaemia A gene in breast tumours with loss of heterozygosity at 16q24.3.
    Cleton-Jansen AM; Moerland EW; Pronk JC; van Berkel CG; Apostolou S; Crawford J; Savoia A; Auerbach AD; Mathew CG; Callen DF; Cornelisse CJ
    Br J Cancer; 1999 Mar; 79(7-8):1049-52. PubMed ID: 10098735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TTC4, a novel human gene containing the tetratricopeptide repeat and mapping to the region of chromosome 1p31 that is frequently deleted in sporadic breast cancer.
    Su G; Roberts T; Cowell JK
    Genomics; 1999 Jan; 55(2):157-63. PubMed ID: 9933562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.